JP5654989B2 - グッドパスチャー抗原結合タンパク質およびその検出 - Google Patents

グッドパスチャー抗原結合タンパク質およびその検出 Download PDF

Info

Publication number
JP5654989B2
JP5654989B2 JP2011519076A JP2011519076A JP5654989B2 JP 5654989 B2 JP5654989 B2 JP 5654989B2 JP 2011519076 A JP2011519076 A JP 2011519076A JP 2011519076 A JP2011519076 A JP 2011519076A JP 5654989 B2 JP5654989 B2 JP 5654989B2
Authority
JP
Japan
Prior art keywords
gpbp
kda
polypeptide
antibody
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2011519076A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011528559A (ja
JP2011528559A5 (enExample
Inventor
サウス、ファン
レベルト、フェルナンド
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
FibroStatin SL
Original Assignee
FibroStatin SL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by FibroStatin SL filed Critical FibroStatin SL
Publication of JP2011528559A publication Critical patent/JP2011528559A/ja
Publication of JP2011528559A5 publication Critical patent/JP2011528559A5/ja
Application granted granted Critical
Publication of JP5654989B2 publication Critical patent/JP5654989B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • G16H10/60—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for patient-specific data, e.g. for electronic patient records
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/23—Immunoglobulins specific features characterized by taxonomic origin from birds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/54—F(ab')2
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y207/00—Transferases transferring phosphorus-containing groups (2.7)
    • C12Y207/11—Protein-serine/threonine kinases (2.7.11)
    • C12Y207/11009—Goodpasture-antigen-binding protein kinase (2.7.11.9)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/91—Transferases (2.)
    • G01N2333/912—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
    • Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Primary Health Care (AREA)
  • Public Health (AREA)
  • Medical Informatics (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
JP2011519076A 2008-07-22 2009-07-20 グッドパスチャー抗原結合タンパク質およびその検出 Expired - Fee Related JP5654989B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US8274108P 2008-07-22 2008-07-22
US61/082,741 2008-07-22
US8521108P 2008-07-31 2008-07-31
US61/085,211 2008-07-31
PCT/EP2009/005258 WO2010009856A2 (en) 2008-07-22 2009-07-20 Goodpasture antigen binding protein and its detection

Publications (3)

Publication Number Publication Date
JP2011528559A JP2011528559A (ja) 2011-11-24
JP2011528559A5 JP2011528559A5 (enExample) 2012-08-30
JP5654989B2 true JP5654989B2 (ja) 2015-01-14

Family

ID=41202276

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011519076A Expired - Fee Related JP5654989B2 (ja) 2008-07-22 2009-07-20 グッドパスチャー抗原結合タンパク質およびその検出

Country Status (6)

Country Link
US (3) US7935492B2 (enExample)
EP (1) EP2318039B1 (enExample)
JP (1) JP5654989B2 (enExample)
CN (1) CN102300583A (enExample)
ES (1) ES2535258T3 (enExample)
WO (1) WO2010009856A2 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010009856A2 (en) * 2008-07-22 2010-01-28 Juan Saus Goodpasture antigen binding protein and its detection
AU2012219582A1 (en) 2011-02-21 2013-08-22 Fibrostatin S.L. Methods for treating and diagnosing disease
US9066938B2 (en) 2012-07-02 2015-06-30 Fibrostein, S.L. GPBP-1 inhibition and its therapeutic use
JP2016534981A (ja) * 2013-09-27 2016-11-10 フィブロスタティン，エス．エル． 糖尿病におけるグッドパスチャー抗原結合タンパク質の検出および阻害ならびにその使用
US20160184274A1 (en) 2014-12-31 2016-06-30 Fibrostatin, S.L. Methods for inhibiting mesenchymal phenotype after epithelial-to-mesenchymal transition
CN107966569A (zh) * 2017-12-27 2018-04-27 湖北普罗金科技有限公司 一种具有冷却通风功能的蛋白质鉴定工作台
WO2025032091A1 (en) * 2023-08-08 2025-02-13 F. Hoffmann-La Roche Ag Peptide biomarker for neurological disease, in particular motor neuron disease
CN119322175A (zh) * 2024-10-18 2025-01-17 武汉塞力斯生物技术有限公司 一种血管炎抗体联检试剂盒

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5776427A (en) 1992-03-05 1998-07-07 Board Of Regents, The University Of Texas System Methods for targeting the vasculature of solid tumors
US5625048A (en) 1994-11-10 1997-04-29 The Regents Of The University Of California Modified green fluorescent proteins
US6124128A (en) 1996-08-16 2000-09-26 The Regents Of The University Of California Long wavelength engineered fluorescent proteins
AU760197B2 (en) * 1999-02-24 2003-05-08 Fibrostatin, Sociedad Limitada Goodpasture antigen binding protein
US6881547B1 (en) 2001-01-31 2005-04-19 Juan Saus Methods and reagents for treating autoimmune disorders
US7147855B2 (en) 2001-12-07 2006-12-12 Juan Saus GIPs, a family of polypeptides with transcription factor activity that interact with goodpasture antigen binding protein
US7326768B2 (en) 2003-02-05 2008-02-05 Juan Saus Goodpasture antigen-binding protein isoforms and protein misfolded-mediated disorders
WO2010009856A2 (en) * 2008-07-22 2010-01-28 Juan Saus Goodpasture antigen binding protein and its detection

Also Published As

Publication number Publication date
US20100021935A1 (en) 2010-01-28
JP2011528559A (ja) 2011-11-24
CN102300583A (zh) 2011-12-28
ES2535258T3 (es) 2015-05-07
WO2010009856A2 (en) 2010-01-28
US20110189707A1 (en) 2011-08-04
EP2318039B1 (en) 2015-04-08
US7935492B2 (en) 2011-05-03
WO2010009856A3 (en) 2010-05-20
US20150064716A1 (en) 2015-03-05
EP2318039A2 (en) 2011-05-11

Similar Documents

Publication Publication Date Title
JP5654989B2 (ja) グッドパスチャー抗原結合タンパク質およびその検出
US20230071609A1 (en) Apolipoprotein L1-Specific Antibodies and Methods of Use
JP2016514091A (ja) トランスサイレチン抗体およびその使用
US20240368257A1 (en) Filamin a binding proteins and uses thereof
RU2770006C2 (ru) Антитела к фактору ix padua
US20220363738A1 (en) Method
JP5147696B2 (ja) 可溶型ｌｏｘ−１に対するモノクローナル抗体
US11629183B2 (en) Monoclonal antibodies targeting microtubule-binding domain of tau protein and methods of detecting tau protein in vivo
EP3917571A1 (en) Cnx/erp57 inhibitor for use in the treatment or prevention of cancer
WO2005090971A1 (en) Anti-lipid rafts antibodies
JP7316592B2 (ja) 抗ｎｉｎｊ－１抗体及びその使用
WO2024101357A1 (ja) コートマータンパク質複合体サブユニットベータ２に対する抗体
JP2024509683A (ja) 抗ｐｔ２１７ ｔａｕ抗体
Köppen et al. Identification of isoaspartate-modified transthyretin as potential target for selective immunotherapy of transthyretin amyloidosis
Dubberke¹ et al. of Specific Monoclonal Antibodies and Nanobodies Directed Against the
TW201139459A (en) Osteopontin-specific monoclonal antibodies
KR20240126863A (ko) 헌팅턴병 치료용 조성물 및 방법
WO2020100779A1 (ja) ｐＳｅｒ４６－ＭＡＲＣＫＳに特異的に結合するモノクローナル抗体
HK40085952A (en) Apolipoprotein l1-specific antibodies and methods of use
WO2020257636A1 (en) Neutralizing antibodies to human endothelin

Legal Events

Date Code Title Description
RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20120123

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20120709

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20120709

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20140121

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20140418

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20141104

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20141121

R150 Certificate of patent or registration of utility model

Ref document number: 5654989

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees